Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?

Authors

  • Hashem B. El-Serag,

    Corresponding author
    1. Section of Gastroenterology and Hepatology, Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX
    2. Houston VA HSR&D Center of Excellence Houston, TX
    • Address reprint requests to: Hashem B. El-Serag, M.D., MPH, Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard (152), Houston, TX 77030. E-mail: hasheme@bcm.edu; fax 713-748-7359.

    Search for more papers by this author
  • Fasiha Kanwal

    1. Section of Gastroenterology and Hepatology, Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX
    2. Houston VA HSR&D Center of Excellence Houston, TX
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

  • This work is funded, in part, by the Houston VA HSR&D Center of Excellence (HFP90-020) and the Texas Digestive Disease Center NIH DK58338. Dr. El-Serag is also supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K24-04-107).

  • The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government.

Ancillary